Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06799364

Fermented Dairy Product and Bifidobacterium Diversity (ThreeBees)

A Randomised, Controlled, Double-blind, Three Parallel Groups, Multi-centre Study to Assess the Bifidobacterium Diversity After 28-days Consumption of Fermented Dairy Products With Three Bifidobacterium Strains With or Without Galacto-oligosaccharides Compared to Yoghurt in 45 to 60-year-old Healthy Subjects

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
182 (actual)
Sponsor
Danone Global Research & Innovation Center · Industry
Sex
All
Age
45 Years – 60 Years
Healthy volunteers
Accepted

Summary

Bifidobacterium strains with potential health benefits can contribute to the gastrointestinal wellbeing. However, the ability of these strains to survive gastro-intestinal tract stress and their impact on gut microbiome remains to be clarified. Moreover, prebiotic fibres, such as galacto-oligosaccharides (GOS) can promote the proliferation of Bifidobacteria. This is why the current study aims to assess the impact of Bifidobacteria consumption on human gut microbiome with or without GOS compared to control product.

Conditions

Interventions

TypeNameDescription
OTHER28-days consumption of Product A in 45 to 60-year-old healthy subjects.48 healthy volunteers will consume Product A twice per day during 28 consecutive days.
OTHER28-days consumption of Product B in 45 to 60-year-old healthy subjects.48 healthy volunteers will consume Product B twice per day during 28 consecutive days.
OTHER28-days consumption of Control product in 45 to 60-year-old healthy subjects.48 healthy volunteers will consume Control product twice per day during 28 consecutive days.

Timeline

Start date
2025-02-21
Primary completion
2025-12-22
Completion
2026-04-01
First posted
2025-01-29
Last updated
2026-01-14

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT06799364. Inclusion in this directory is not an endorsement.